---
title: Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues,
  May 24, 2023
date: '2024-02-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38341355/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240211170654&v=2.18.0
source: heidelberg[Affiliation]
description: Many aspects of Controlled Human Infection Models (CHIMs, also known
  as human challenge studies and human infection studies) have been discussed extensively,
  including Good Manufacturing Practice (GMP) production of the challenge agent, CHIM
  ethics, environmental safety in CHIM, recruitment, community engagement, advertising
  and incentives, pre-existing immunity, and clinical, immunological, and microbiological
  endpoints. The fourth CHIM meeting focused on regulation of CHIM studies, ...
disable_comments: true
---
Many aspects of Controlled Human Infection Models (CHIMs, also known as human challenge studies and human infection studies) have been discussed extensively, including Good Manufacturing Practice (GMP) production of the challenge agent, CHIM ethics, environmental safety in CHIM, recruitment, community engagement, advertising and incentives, pre-existing immunity, and clinical, immunological, and microbiological endpoints. The fourth CHIM meeting focused on regulation of CHIM studies, ...